Whose research led to the first vaccine against Ebola?
Quick Answer
The first licensed Ebola vaccine, Ervebo, emerged from many years of research by scientists including Heinz Feldmann and teams at public-health institutes and industry partners. It was licensed in 2019 for Ebola Zaire.
The Full Story
No single person is solely responsible for the Ebola vaccine, but scientists such as Heinz Feldmann were central to the virology and animal-model research that advanced development. The rVSV-ZEBOV vaccine, later marketed as Ervebo, was licensed in 2019. It was first deployed during outbreaks in the Democratic Republic of the Congo and used in ring vaccination strategies similar to those used for smallpox. The vaccine became an important tool against one of the worldβs deadliest viral diseases.
Key Facts
YouTube Angle
Suggested video title for this topic:
"How scientists finally got ahead of Ebola"